PLUS1
4.87
-0.39 (-7.41%)
-0.39 (-7.41%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Seelos Therapeutics Inc | SEEL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.39 | -7.41% | 4.87 | 19:56:47 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.26 | 4.88 | 5.34 | 4.93 | 5.26 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.89 | 4.93 | 0.04 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,465 | 3,894,142 | $ 5.04 | $ 19,627,681 | 2,911,830 | 0.4426 - 6.16 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:12 | 5 | $ 4.88 | USD |
Seelos Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 264.92M | 54.40M | 51.18M | $ 375.00k | $ - | -4.47 | -4.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Seelos Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/06/2021 | 07:52 | Seeking Alpha | Seelos partners with AptarGroup for drug delivery system |
| 4/06/2021 | 07:00 | PR Newswire (US) | Seelos Therapeutics Announces a Strategic Device Partnership.. |
| 4/01/2021 | 16:14 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting.. |
| 3/12/2021 | 08:23 | Seeking Alpha | NVAX, MVIS, LB and AVEO among premarket gainers |
| 3/12/2021 | 07:43 | Seeking Alpha | Seelos surges in premarket as BTIG initiates with street.. |
| 3/11/2021 | 16:17 | Edgar (US Regulatory) | Annual Report (10-k) |
| 3/05/2021 | 09:10 | Seeking Alpha | Seelos completes enrollment in part 1 of SLS-002 suicidal.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SEEL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.66 | 6.16 | 4.88 | 5.50 | 6,668,457 | -0.79 | -13.96% |
| 1 Month | 4.20 | 6.16 | 3.61 | 4.84 | 7,389,256 | 0.67 | 15.95% |
| 3 Months | 1.70 | 6.16 | 1.6205 | 4.45 | 15,637,704 | 3.17 | 186.47% |
| 6 Months | 0.87 | 6.16 | 0.722 | 4.19 | 8,190,513 | 4.00 | 459.77% |
| 1 Year | 0.4672 | 6.16 | 0.4426 | 3.65 | 4,774,325 | 4.40 | 942.38% |
| 3 Years | 4.02 | 8.00 | 0.4195 | 3.37 | 2,928,162 | 0.85 | 21.14% |
| 5 Years | 4.02 | 8.00 | 0.4195 | 3.37 | 2,928,162 | 0.85 | 21.14% |
Seelos Therapeutics Description
| Seelos Therapeutics Inc is engaged in the pharmaceutical industry. The company's pipeline products include SLS-002 which is intranasal racemic ketamine for patients with suicidality in post-traumatic stress disorder and depressive disorder; SLS-006 which is a small molecule, partial dopamine agonist for Parkinson's Disease; and SLS-005 is Trehalose, a protein stabilizer. Its other pipeline products include SLS-007, SLS-008, SLS-004, SLS-010, and SLS-012. |
